MODULE SPECIFICATION. 4.1 Catapult will ensure the Manufacturing Space will be in accordance with the specifications at Schedule 12 Part A and will at all times comply with Applicable Laws (including GMP Requirements). 4.2 Catapult will ensure the Manufacturing Office and Non-Manufacturing Office will be in accordance with the specifications at Schedule 12 Part B. 4.3 Catapult will also ensure that use of the Shared Restricted Access Areas and Warehouse Space will at all times comply with Applicable Laws including EU-GMP Requirements, in relation to any collaborator other than COLLABORATOR.
Appears in 2 contracts
Sources: Collaboration Agreement (Freeline Therapeutics Holdings PLC), Collaboration Agreement (Freeline Therapeutics Holdings LTD)
MODULE SPECIFICATION. 4.1 Catapult will ensure the Manufacturing Space will be in accordance with the specifications at Schedule 12 Part A and will at all times comply with Applicable Laws (including GMP Requirements).
4.2 Catapult will ensure the Manufacturing Office and Non-Manufacturing Office will be in accordance with the specifications at Schedule 12 Part B.
4.3 Catapult will also ensure that use of the Shared Restricted Access Areas and Warehouse Space will at all times comply with Applicable Laws including EU-GMP Requirements, in relation to any collaborator Collaborator other than COLLABORATORADAPTIMMUNE.
Appears in 1 contract
Sources: Collaboration Agreement (Adaptimmune Therapeutics PLC)